Entry Point Capital, LLC Evolus, Inc. Transaction History

Entry Point Capital, LLC

  • $171 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$10.45 - $13.76 $36,700 - $48,325
3,512 Added 185.92%
5,401 $58.6 Million
Q1 2024

May 14, 2024
SELL
$9.99 - $14.91 $131,578 - $196,379
-13,171 Reduced 87.46%
1,889 $26.4 Million
Q4 2023

Feb 14, 2024
BUY
$7.6 - $10.53 $114,456 - $158,581
15,060 New
15,060 $159 Million

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email